Created at Source Raw Value Validated value
June 25, 2024, noon usa

* age \< 18 * pregnancy or breastfeeding * known allergy to iodinated contrast dye * severe vasoplegic shock: norepinephrine \> 300 ng/kg\*min * glomerular filtration rate \< 30 ml/min * active bleeding or absolute contraindication to anticoagulant therapy (stroke (intracranial hemorrhage, hemorrhagic stroke), including a history of the last 6 months.; cancer of the central nervous system and other localities with an increased risk of bleeding, vascular aneurysm, traumatic open heart massage, obstetric delivery, general operations, severe uncontrolled hypertension, gastric ulcer and 12-duodenal ulcer (for 3 months. from the moment of exacerbation), arterial or venous malformations, liver failure, liver cirrhosis, portal hypertension, esophageal varicose veins, active hepatitis).

* age \< 18 * pregnancy or breastfeeding * known allergy to iodinated contrast dye * severe vasoplegic shock: norepinephrine \> 300 ng/kg\*min * glomerular filtration rate \< 30 ml/min * active bleeding or absolute contraindication to anticoagulant therapy (stroke (intracranial hemorrhage, hemorrhagic stroke), including a history of the last 6 months.; cancer of the central nervous system and other localities with an increased risk of bleeding, vascular aneurysm, traumatic open heart massage, obstetric delivery, general operations, severe uncontrolled hypertension, gastric ulcer and 12-duodenal ulcer (for 3 months. from the moment of exacerbation), arterial or venous malformations, liver failure, liver cirrhosis, portal hypertension, esophageal varicose veins, active hepatitis).

Oct. 26, 2020, 11:31 p.m. usa

- age < 18 - pregnancy or breastfeeding - known allergy to iodinated contrast dye - severe vasoplegic shock: norepinephrine > 300 ng/kg*min - glomerular filtration rate < 30 ml/min - active bleeding or absolute contraindication to anticoagulant therapy (stroke (intracranial hemorrhage, hemorrhagic stroke), including a history of the last 6 months.; cancer of the central nervous system and other localities with an increased risk of bleeding, vascular aneurysm, traumatic open heart massage, obstetric delivery, general operations, severe uncontrolled hypertension, gastric ulcer and 12-duodenal ulcer (for 3 months. from the moment of exacerbation), arterial or venous malformations, liver failure, liver cirrhosis, portal hypertension, esophageal varicose veins, active hepatitis).

- age < 18 - pregnancy or breastfeeding - known allergy to iodinated contrast dye - severe vasoplegic shock: norepinephrine > 300 ng/kg*min - glomerular filtration rate < 30 ml/min - active bleeding or absolute contraindication to anticoagulant therapy (stroke (intracranial hemorrhage, hemorrhagic stroke), including a history of the last 6 months.; cancer of the central nervous system and other localities with an increased risk of bleeding, vascular aneurysm, traumatic open heart massage, obstetric delivery, general operations, severe uncontrolled hypertension, gastric ulcer and 12-duodenal ulcer (for 3 months. from the moment of exacerbation), arterial or venous malformations, liver failure, liver cirrhosis, portal hypertension, esophageal varicose veins, active hepatitis).